GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection

Citation
Bertoccini L, Baroni MG. Adv Exp Med Biol 2020; epub ahead of press.